Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Cancer Cell

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Improving immunotherapy response through the use of designer bacteria.  39:1576-1577. 2021
  • Immunogenic Chemotherapy Enhances Recruitment of CAR-TCells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade.  39:193-208. 2020
  • Intratumor heterogeneity: The Rosetta Stone of therapy resistance.  37:471-484. 2020
  • Therapeutic targeting of CDK12/CDK13 in triple-negative breast cancer.  36:545-558. 2019
  • Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.  35:916-931. 2019
  • Logic-gated ROR1 chimeric antigen receptor expression rescues T cell-mediated toxicity to normal tissues and enables selective tumor targeting.  35:489-503. 2019
  • NRF2 and the hallmarks of cancer.  34:21-43. 2018
  • EWS/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma.  33:202-216. 2018
  • Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.  34:792-+. 2018
  • Employing metabolism to improve the diagnosis and treatment of pancreatic cancer.  31:5-19. 2017
  • MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer.  32:71-87. 2017
  • An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers.  30:683-693. 2016
  • EZH2 and BCL6 cooperate to assemble CBX8-BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis.  30:197-213. 2016
  • A biparatopic HER2-targeting antibody-drug conjugate induces tumor regression in primary models refractory to or ineligible for HER2-targeted therapy.  29:117-129. 2016
  • Targeting aberrant epigenetic networks mediated by PRMT1 and KDM4C in acute myeloid leukemia.  29:32. 2016
  • Efficacy of retinoids in IKZF1-mutated BCR-ABL1 acute lymphoblastic leukemia.  28:343-356. 2015
  • Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis.  28:42-56. 2015
  • Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.  27:644-657. 2015
  • Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.  27:327-341. 2015
  • The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells.  27:193-210. 2015
  • MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.  25:469-483. 2014
  • Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.  25:516-529. 2014
  • The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.  23:332-346. 2013
  • Platelets alter tumor cell attributes to propel metastasis: programming in transit.  20:553-554. 2011
  • An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.  20:384-399. 2011
  • A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions.  19:527-540. 2011
  • A stapled p53 helix overcomes HDMX-mediated suppression of p53.  18:411-422. 2010
  • Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.  18:258-267. 2010
  • Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.  14:299-311. 2008
  • The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin cd151.  13:221-234. 2008
  • The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel.  10:177-178. 2006
  • Targeting ornithine decarboxylase in myc-induced lymphomagenesis prevents tumor formation.  7:433-444. 2005
  • Inhibition of NF-kappa B in cancer cells converts inflammation-induced tumor growth mediated by TNF alpha to TRAIL-mediated tumor regression.  6:297-305. 2004
  • Targeted disruption of beta 1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.  6:159-170. 2004
  • Naturally death-resistant precursor cells revealed as the origin of retinoblastoma.  5:513-515. 2004
  • Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.  4:321-328. 2003
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1535-6108

Electronic International Standard Serial Number (EISSN)

  • 1878-3686

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support